Eosinophilia: approaches to differential diagnosis of reactive and clonal eosinophilia



Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The features of changes in blood and bone marrow of patients with reactive (1 group, n = 8) and clonal (2 group, n = 13)eosinophilia. Revealed correlations between cellular elements, depending on the etiology, a statistically significant difference between the two independent groups of patients in terms of cellular composition of the blood and bone marrow. A common feature of both groups was high blood eosinophil counts and eosinophilic hyperplasia of the bone marrow. The absence of the correlation of some indicators of peripheral blood and hematopoietic progenitors in the bone marrow in patients 1 and 2 groups. Compared with patients with reactive eosinophilias number of correlations between indicators of hemogram and myelogram in patients with klonal eosinophilias were significantly less. Identified weak false-positive relationship between the number of neutrophils in the blood and bone marrow's neutrophils with monoclonal eosinophilias. Correlation of eosinophils and basophils blood in patients with klonal eosinophilias has been declared negative (p>0.05). On the contrary, there was a clear correlation between the two groups of red blood cells and eosinophils and their precursors. It is suggested the possible disregulatory process occurring under the action of the cytokine environment hematopoietic cells in hematologic malignancies.

Full Text

Restricted Access

About the authors

S. V Bondarchuk

S.M. Kirov Military Medical Academy

Saint Petersburg, Russia

A. A Sevruk

S.M. Kirov Military Medical Academy

Saint Petersburg, Russia

V. N Semelev

S.M. Kirov Military Medical Academy

Saint Petersburg, Russia

References

  1. Туркина А.Г., Немченко И.С., Челышева Е.Ю. и др. Национальные клинические рекомендации. Диагностика и лечение миелопролиферативных заболеваний с эозинофилией и идиопатического гиперэозинофильного синдрома. Гематология и трансфузиология 2016; 61 (1 Прил. 3): 1-24.
  2. Лобзин Ю.В., ред. Руководство по инфекционным болезням. СПб.: Фолиант; 2000.
  3. Бондарчук С.В., Михалева М.А., Тыренко В.В. и др. Вариативные показатели гемограммы у курсантов и слушателей Военномедицинской академии им. С.М. Кирова. Вестник Росс. Воен. Мед. Акад. 2016; 2(54): 76-80.
  4. Valent P. Pathogenesis, classification, and therapy of eosinophilia and eosinophil disorders. Blood Rev. 2009; 23(4): 157-65.
  5. Мамаев Н.Н., ред. Гематология: руководство для врачей. СПб.: СпецЛит; 2011.
  6. Богданов А.Н., Мазуров В.И., ред. Клиническая гематология: руководство для врачей. СПб.: Фолиант; 2008.
  7. Волкова М.А., ред. Клиническая онкогематология: руководство для врачей. М.: Медицина; 2007.
  8. Spencer L.A., Szela C.T., Perez S.A. et al. Human eosinophils constitutively express multiple Th1, Th2 and immunoregulatory cytokines that are secreted rapidly and differentially. J. Leukoc. Biol. 2009; 85(1): 117-23.
  9. Roufosse F., Weller P.F. Practical approach to the patient with hypereosinophilia. J. Allergy Clin. Immunol. 2010; 126(1): 39-44.
  10. Hudson S.A., Bovin N.V., Schnaar R.L. et al. Eosinophil-selective binding and proapoptotic effect in vitro of a synthetic Siglec-8 ligand,
  11. polymeric 6'-sulfated sialyl Lewis X. J. Pharmacol. Exp. Ther. 2009; 330(2): 608-12.
  12. Neves J.S., Weller P.F. Functional extracellular eosinophil granules: novel implications in eosinophil immunobiology. Curr. Opin. Immunol. 2009; 21(6): 694-9.
  13. Valent P., Klion A.D., Horny H.P. et al. Contemporary consensus on criteria and classification of eosinophil disorders and related syndromes. J. Allergy Clin. Immunol. 2012; 130: 607-12.
  14. Wasag B., Lierman E., Meeus P. et al. The kinase inhibitor TKI258 is active against the novel CUX1-FGFR1 fusion detected in a patient with T-lymphoblastic leukemia/lymphoma and t(7;8)(q22;p11). Haematologica 2011; 96(6): 922-6.
  15. Ogbogu P.U., Bochner B.S., Butterfield J.H. et. al. Hypereosinophilic syndrome: A multicenter, retrospective analysis of clinical characteristics and response to therapy. J. Allergy Clin. Immunol. 2009; 124: 1319-25.
  16. Bain B.J. Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1. Haematologica 2010; 95(5): 696-8.
  17. Гематологические анализаторы. Интерпретация анализа крови. Методические рекомендации Минздравсоцразвития РФ №2050-РХ; 2007.
  18. Рукавицин О.А., ред. Гематология: национальное руководство. М.: ГЭОТАР-Медиа; 2015.
  19. Абдулкадыров К.М., ред. Гематология: новейший справочник. М.: ЭКСМО; 2004.
  20. Gotlib J. CME Information: World Health Organization-defined eosinophilic disorders: 2015 update on diagnosis, risk stratification, and management. Am. J. Hematol. 2015; 90(11): 1077-89

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2016 Eco-Vector



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: 

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies